BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12213212)

  • 1. Suppression of the transformed phenotype of breast cancer by tropomyosin-1.
    Mahadev K; Raval G; Bharadwaj S; Willingham MC; Lange EM; Vonderhaar B; Salomon D; Prasad GL
    Exp Cell Res; 2002 Sep; 279(1):40-51. PubMed ID: 12213212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors.
    Raval GN; Bharadwaj S; Levine EA; Willingham MC; Geary RL; Kute T; Prasad GL
    Oncogene; 2003 Sep; 22(40):6194-203. PubMed ID: 13679858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of src-induced transformed phenotype by expression of tropomyosin-1.
    Prasad GL; Masuelli L; Raj MH; Harindranath N
    Oncogene; 1999 Mar; 18(11):2027-31. PubMed ID: 10208425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins.
    Shah V; Braverman R; Prasad GL
    Somat Cell Mol Genet; 1998 Sep; 24(5):273-80. PubMed ID: 10696235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
    Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
    Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion.
    Bharadwaj S; Thanawala R; Bon G; Falcioni R; Prasad GL
    Oncogene; 2005 Dec; 24(56):8291-303. PubMed ID: 16170368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells.
    Bharadwaj S; Prasad GL
    Cancer Lett; 2002 Sep; 183(2):205-13. PubMed ID: 12065096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N terminus is essential for tropomyosin functions: N-terminal modification disrupts stress fiber organization and abolishes anti-oncogenic effects of tropomyosin-1.
    Bharadwaj S; Hitchcock-DeGregori S; Thorburn A; Prasad GL
    J Biol Chem; 2004 Apr; 279(14):14039-48. PubMed ID: 14722123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines.
    Bhattacharya B; Prasad GL; Valverius EM; Salomon DS; Cooper HL
    Cancer Res; 1990 Apr; 50(7):2105-12. PubMed ID: 2317800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences.
    Braverman RH; Cooper HL; Lee HS; Prasad GL
    Oncogene; 1996 Aug; 13(3):537-45. PubMed ID: 8760295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.
    Fiucci G; Ravid D; Reich R; Liscovitch M
    Oncogene; 2002 Apr; 21(15):2365-75. PubMed ID: 11948420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of cell adhesion molecules in an ionizing radiation-induced breast cancer model system.
    Calaf GM; Roy D; Narayan G; Balajee AS
    Oncol Rep; 2013 Jul; 30(1):285-91. PubMed ID: 23670055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of tropomyosin-1 in squamous cell carcinoma of esophagus, the role of Ras signaling and methylation.
    Zare M; Jazii FR; Soheili ZS; Moghanibashi MM
    Mol Carcinog; 2012 Oct; 51(10):796-806. PubMed ID: 22965424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced expression of tropomyosin 2 or 3 in v-Ki-ras-transformed fibroblasts results in distinct phenotypic effects.
    Gimona M; Kazzaz JA; Helfman DM
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9618-23. PubMed ID: 8790379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of microfilament bundle organization in v-raf-transformed NRK cells after transduction with tropomyosin 2 cDNA.
    Takenaga K; Masuda A
    Cancer Lett; 1994 Nov; 87(1):47-53. PubMed ID: 7954369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene.
    Prasad GL; Fuldner RA; Cooper HL
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7039-43. PubMed ID: 8346214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropomyosin as a regulator of cancer cell transformation.
    Helfman DM; Flynn P; Khan P; Saeed A
    Adv Exp Med Biol; 2008; 644():124-31. PubMed ID: 19209818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of the actin-binding protein, tropomyosin 1, in neuroblastoma.
    Yager ML; Hughes JA; Lovicu FJ; Gunning PW; Weinberger RP; O'Neill GM
    Br J Cancer; 2003 Sep; 89(5):860-3. PubMed ID: 12942118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts.
    Janssen RA; Mier JW
    Mol Biol Cell; 1997 May; 8(5):897-908. PubMed ID: 9168473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.